Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/1997
02/06/1997CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease
02/06/1997CA2227339A1 Synthetic hpv11 virus-like particles
02/06/1997CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
02/06/1997CA2227184A1 Window texture extraction for image analysis
02/06/1997CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins
02/06/1997CA2227013A1 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
02/06/1997CA2226679A1 Stress testing and relieving method and apparatus
02/06/1997CA2225145A1 In vivo diabetes test
02/05/1997EP0757252A2 Electrochemiluminescent assays
02/05/1997EP0757251A2 Estimation of change in bone mineral density and diagnosis of osteoporosis
02/05/1997EP0757250A1 Method of assaying asialoglycoprotein receptor and assay reagent therefor
02/05/1997EP0757249A1 Method of determining the suppressor cell component of the immune status of an individual and means for carrying out the same
02/05/1997EP0757248A2 Improved capsule chemistry analytical methods employing dioxetane chemiluminescence
02/05/1997EP0757247A2 Aqueous sample testing apparatus
02/05/1997EP0757244A2 Improvements in or relating to aqueous sample testing apparatus
02/05/1997EP0757106A2 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same
02/05/1997EP0757105A2 Serum markers as predictors of adult respiratory distress syndrome
02/05/1997EP0757102A1 Genetic transformation using a PARP inhibitor
02/05/1997EP0757052A1 Di-substituted 1,2-dioxetane compounds having increased water solubility and assay compositions
02/05/1997EP0757017A2 Method to monitor in liquids the concentration of substances which are degraded by acidifying or alkalizing microorganisms and related instrumentation
02/05/1997EP0756709A1 Method of selection of a population or subpopulation of a sample
02/05/1997EP0756708A1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation
02/05/1997EP0756642A1 Process for keeping a metallurgical vessel opening free from deposits
02/05/1997EP0756641A1 Process and device for keeping a metallurgical vessel opening free from deposits
02/05/1997EP0756640A1 Device for introducing a lance into a metallurgical vessel
02/05/1997EP0756638A1 Method and means for detecting and treating disorders in the blood coagulation cascade
02/05/1997EP0756637A1 Methods for calibrating chemical assays
02/05/1997EP0756635A1 Biochemical sensor
02/05/1997EP0756630A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
02/05/1997EP0756628A1 Morphogenic protein-specific cell surface receptors and uses therefor
02/05/1997EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
02/05/1997EP0756626A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
02/05/1997EP0756604A1 Melanoma antigens
02/05/1997EP0756490A1 Human bone stimulating factor
02/05/1997EP0756488A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
02/05/1997EP0716740B1 Method for activation of polyanionic fluorescent dyes in low dielectric media with quaternary onium compounds
02/05/1997EP0695419B1 Method and apparatus for compacting material samples
02/05/1997EP0671006B1 Immunologic rapid test for the optical determination of progesterone in fluids
02/05/1997EP0669968B1 Anilines as marking agents for mineral oils
02/05/1997EP0656929B1 Use of compounds which absorb and/or fluoresce in the i/r range as markers for liquids
02/05/1997EP0606296A4 Reagents and assay methods including a phenazine-containing indicator.
02/05/1997EP0599956B1 Assay method
02/05/1997EP0595922B1 A test method
02/05/1997EP0533826B1 NOx SENSOR AND PROCESS FOR DETECTING NOx
02/05/1997EP0463144B1 Magnetically responsive fluorescent polymer particles and application thereof
02/05/1997CN1142188A 人生长激素 Human Growth Hormone
02/04/1997US5600134 Method for preparing blend products
02/04/1997US5599918 Nucleic acids encoding trophinin and trophinin-assisting proteins
02/04/1997US5599909 Process for reactivating purified membrane proteins
02/04/1997US5599905 Interleukin-4 receptors
02/04/1997US5599904 Encoded by dna carried on plsmid; glucocorticoid/mineralocorticoid/thyroid hormone/retinoic acid and estrogen related receptors
02/04/1997US5599903 Glutathione analogs and paralog panels comprising glutathione mimics
02/04/1997US5599844 Administering agent to elevate level of transforming growth factor beta
02/04/1997US5599720 Binding; quantitative analysis
02/04/1997US5599719 Method for isolating biomolecules from a biological sample with linear polymers
02/04/1997US5599718 Measurement of the thrombolytic activity of blood
02/04/1997US5599715 Solution containing buffer(s) and sulfate surfactant; noncrystallizing at low temperature; immunoassays
02/04/1997US5599707 Human prohibitin DNA
02/04/1997US5599693 Culture product
02/04/1997US5599683 Mixing factor xii activator with plasma in the presence of test substance to produce factor xii in active form, adding inhibitor to stop reaction, measuring amount of active factor xii produced
02/04/1997US5599682 Method for the protection of leucocytes and method of blood analysis
02/04/1997US5599679 A polypeptide for immuno-competing binding; immunoassay diagnosing bone disorder
02/04/1997US5599678 Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use
02/04/1997US5599677 Immunoassays for prostate specific antigen
02/04/1997US5599676 Method for isolating a novel receptor for α4 integrins
02/04/1997US5599669 Cytokine-induced marker for inflammatory response
02/04/1997US5599668 Light scattering optical waveguide method for detecting specific binding events
02/04/1997US5599664 Determining the molecular size of a nucleic acid by the conformational or positional change of the molecule after applying a controlled external force
02/04/1997US5599663 Screening hexapeptide as plasminogen activator inhibitor
02/04/1997US5599662 Oliconucleotide primers and probes for the detection of HIV-1
02/04/1997US5599660 Combining first reagent and carrier wax in liquid form, cooling the mixture to solidify; combining solid mixture with second bio or chemical inactive air or freeze dried reagent, solidifying combined mixture in solid support
02/04/1997US5599542 Diagnosis, treatment and vaccine for malaria; induction of antibodies that attack plasmodium in the schizont stage
02/04/1997US5599541 Peptide sequence capable of inducing a delayed-type hypersensitivity reaction in the presence of living bacteria of the Mycobacterium tuberculosis complex and its applications
02/04/1997US5599505 Chemical analysis element cartridge with capping member
02/04/1997US5599501 Incubation chamber
02/04/1997US5599460 Water/glycol sensor for use in oil systems
02/04/1997US5599433 Capillary electrophoresis of glycosylated proteins
02/04/1997US5599407 Method for estimating inclusion content of metals using reflectance
02/04/1997CA2182545A1 Direct-reading reagent test strip
02/02/1997CA2182457A1 Acridinium compound having a plurality of luminescent groups and binding groups, and conjugate thereof
02/02/1997CA2182433A1 Method to monitor in liquids the concentration of substances which are degraded by acidifying or alkalizing microorganisms and related instrumentation
02/01/1997CA2182326A1 Capsule chemistry analytical methods employing dioxetane chemiluminescence
01/1997
01/30/1997WO1997003363A1 Prenatal urinary screening for down syndrome and other aneuploidies
01/30/1997WO1997003362A1 Methods and articles of manufacture for the detection of cryptosporidium oocysts
01/30/1997WO1997003361A1 Elisa serodiagnosis of pig pleuropneumonia serotypes 1, 9 and 11
01/30/1997WO1997003359A1 Helicobacter clpb
01/30/1997WO1997003358A1 Method of identifying inhibitors of the jak-stat signal transduction pathway
01/30/1997WO1997003357A1 Improvements in or relating to binding assays
01/30/1997WO1997003356A1 Process for determining the effectiveness and tolerance of a xenogenic substance administered to an organism
01/30/1997WO1997003355A1 Portable hand-held device with a biosensor
01/30/1997WO1997003354A1 Method and apparatus for the measurement of dissolved carbon
01/30/1997WO1997003348A1 Self-contained device integrating nucleic acid extraction, amplification and detection
01/30/1997WO1997003347A1 Light transmittance type analytical system, variable transmittance optical component, and test device
01/30/1997WO1997003209A1 Test apparatus, system and method for the detection of test samples
01/30/1997WO1997003090A2 Nuclear localized transcription factor kinase and diagnostic assays related thereto
01/30/1997WO1997003087A1 Novel regulatory genes
01/30/1997WO1997003086A1 Early onset alzheimer's disease gene and gene products
01/30/1997WO1997002892A1 Distributor device, in particular for a chemical analysis arrangement
01/30/1997WO1996041146A3 Apparatus for measuring the crush recovery of an absorbent article
01/30/1997WO1996039513A3 Ebnerin cloning of a secreted von ebner's gland protein